Your browser doesn't support javascript.
loading
Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy (the NeoFit Trial): protocol for a national, multicenter single-arm trial.
Delrieu, Lidia; Hamy, Anne-Sophie; Coussy, Florence; Kassara, Amyn; Asselain, Bernard; Antero, Juliana; De Villèle, Paul; Dumas, Elise; Forstmann, Nicolas; Guérin, Julien; Hotton, Judicael; Jouannaud, Christelle; Milder, Maud; Leopold, Armand; Sedeaud, Adrien; Soibinet, Pauline; Toussaint, Jean-François; Vercamer, Vincent; Laas, Enora; Reyal, Fabien.
Afiliación
  • Delrieu L; Residual Tumor & Response To Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, University Paris, Paris, France.
  • Hamy AS; Residual Tumor & Response To Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, University Paris, Paris, France.
  • Coussy F; Department of Medical Oncology, Institut Curie, University Paris, Paris, France.
  • Kassara A; Residual Tumor & Response To Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, University Paris, Paris, France.
  • Asselain B; Department of Medical Oncology, Institut Curie, University Paris, Paris, France.
  • Antero J; Residual Tumor & Response To Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, University Paris, Paris, France.
  • De Villèle P; GINECO Group, Paris, France.
  • Dumas E; Institute for Biomedical and Epidemiological Research in Sport, France University, EA7329, Paris, France.
  • Forstmann N; Institut National du Sport de L'Expertise Et de La Performance, INSEP, Paris, France.
  • Guérin J; , Withings, Issy-les-Moulineaux, Paris, France.
  • Hotton J; Residual Tumor & Response To Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, Institut Curie, University Paris, Paris, France.
  • Jouannaud C; Institute for Biomedical and Epidemiological Research in Sport, France University, EA7329, Paris, France.
  • Milder M; Institut National du Sport de L'Expertise Et de La Performance, INSEP, Paris, France.
  • Leopold A; Data Office, Institut Curie, Paris, France.
  • Sedeaud A; Department of Surgical Oncology, Institut de Cancérologie Jean-Godinot, Reims, France.
  • Soibinet P; Department of Medical Oncology, Institut de Cancérologie Jean-Godinot, Reims, France.
  • Toussaint JF; Data Office, Institut Curie, Paris, France.
  • Vercamer V; Data Office, Institut Curie, Paris, France.
  • Laas E; Institute for Biomedical and Epidemiological Research in Sport, France University, EA7329, Paris, France.
  • Reyal F; Institut National du Sport de L'Expertise Et de La Performance, INSEP, Paris, France.
BMC Cancer ; 22(1): 493, 2022 May 04.
Article en En | MEDLINE | ID: mdl-35509030
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Terapia Neoadyuvante Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Francia